HUTCHMED (China) Limited
HUTCHMED (China) Limited (0013.HK) Stock Competitors & Peer Comparison
See (0013.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0013.HK | HK$24.72 | +0.90% | 21.3B | 5.96 | HK$4.15 | N/A |
| 3692.HK | HK$39.76 | -1.00% | 240.7B | 37.16 | HK$1.07 | +0.92% |
| 2196.HK | HK$20.16 | -1.47% | 75.5B | 13.81 | HK$1.46 | +1.74% |
| 0874.HK | HK$16.86 | -0.94% | 41.9B | 8.03 | HK$2.10 | +5.20% |
| 3320.HK | HK$6.38 | -1.85% | 40.1B | 8.62 | HK$0.74 | +2.11% |
| 0867.HK | HK$13.93 | -0.92% | 34B | 19.62 | HK$0.71 | +2.14% |
| 1513.HK | HK$28.94 | -1.36% | 31.6B | 11.13 | HK$2.60 | +4.14% |
| 0512.HK | HK$6.76 | -0.59% | 23.7B | 11.46 | HK$0.59 | N/A |
| 3933.HK | HK$10.04 | -1.86% | 19.8B | 7.91 | HK$1.27 | +5.67% |
| 2575.HK | HK$33.56 | +1.94% | 17.4B | -55.02 | -HK$0.61 | N/A |
Stock Comparison
0013.HK vs 3692.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 3692.HK has a market cap of 240.7B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 3692.HK trades at HK$39.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 3692.HK's P/E ratio is 37.16. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 3692.HK's ROE of +0.17%. Regarding short-term risk, 0013.HK is less volatile compared to 3692.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 3692.HK's competition here
0013.HK vs 2196.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2196.HK has a market cap of 75.5B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2196.HK trades at HK$20.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2196.HK's P/E ratio is 13.81. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2196.HK's ROE of +0.09%. Regarding short-term risk, 0013.HK is less volatile compared to 2196.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2196.HK's competition here
0013.HK vs 0874.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0874.HK has a market cap of 41.9B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0874.HK trades at HK$16.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0874.HK's P/E ratio is 8.03. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0874.HK's ROE of +0.08%. Regarding short-term risk, 0013.HK is more volatile compared to 0874.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 0874.HK's competition here
0013.HK vs 3320.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 3320.HK has a market cap of 40.1B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 3320.HK trades at HK$6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 3320.HK's P/E ratio is 8.62. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 3320.HK's ROE of +0.08%. Regarding short-term risk, 0013.HK is less volatile compared to 3320.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 3320.HK's competition here
0013.HK vs 0867.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0867.HK has a market cap of 34B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0867.HK trades at HK$13.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0867.HK's P/E ratio is 19.62. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0867.HK's ROE of +0.09%. Regarding short-term risk, 0013.HK is less volatile compared to 0867.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0867.HK's competition here
0013.HK vs 1513.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1513.HK has a market cap of 31.6B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1513.HK trades at HK$28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1513.HK's P/E ratio is 11.13. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1513.HK's ROE of +0.14%. Regarding short-term risk, 0013.HK is less volatile compared to 1513.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1513.HK's competition here
0013.HK vs 0512.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0512.HK has a market cap of 23.7B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0512.HK trades at HK$6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0512.HK's P/E ratio is 11.46. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0512.HK's ROE of +0.07%. Regarding short-term risk, 0013.HK is less volatile compared to 0512.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0512.HK's competition here
0013.HK vs 3933.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 3933.HK has a market cap of 19.8B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 3933.HK trades at HK$10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 3933.HK's P/E ratio is 7.91. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 3933.HK's ROE of +0.13%. Regarding short-term risk, 0013.HK is less volatile compared to 3933.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 3933.HK's competition here
0013.HK vs 2575.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2575.HK has a market cap of 17.4B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2575.HK trades at HK$33.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2575.HK's P/E ratio is -55.02. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2575.HK's ROE of -0.54%. Regarding short-term risk, 0013.HK is less volatile compared to 2575.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2575.HK's competition here
0013.HK vs 9989.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 9989.HK has a market cap of 16.6B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 9989.HK trades at HK$4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 9989.HK's P/E ratio is 18.26. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 9989.HK's ROE of +0.03%. Regarding short-term risk, 0013.HK is more volatile compared to 9989.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 9989.HK's competition here
0013.HK vs 1558.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1558.HK has a market cap of 14B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1558.HK trades at HK$15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1558.HK's P/E ratio is 26.47. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1558.HK's ROE of +0.06%. Regarding short-term risk, 0013.HK is less volatile compared to 1558.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1558.HK's competition here
0013.HK vs 1681.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1681.HK has a market cap of 13.7B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1681.HK trades at HK$16.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1681.HK's P/E ratio is 11.33. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1681.HK's ROE of +0.24%. Regarding short-term risk, 0013.HK is less volatile compared to 1681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1681.HK's competition here
0013.HK vs 6185.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 6185.HK has a market cap of 12.3B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 6185.HK trades at HK$35.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 6185.HK's P/E ratio is -45.71. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 6185.HK's ROE of +0.01%. Regarding short-term risk, 0013.HK is less volatile compared to 6185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 6185.HK's competition here
0013.HK vs 0460.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0460.HK has a market cap of 12.2B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0460.HK trades at HK$1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0460.HK's P/E ratio is 66.50. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0460.HK's ROE of +0.03%. Regarding short-term risk, 0013.HK is less volatile compared to 0460.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0460.HK's competition here
0013.HK vs 2627.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2627.HK has a market cap of 10.6B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2627.HK trades at HK$29.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2627.HK's P/E ratio is -44.42. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2627.HK's ROE of -1.43%. Regarding short-term risk, 0013.HK is less volatile compared to 2627.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2627.HK's competition here
0013.HK vs 0719.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0719.HK has a market cap of 9.6B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0719.HK trades at HK$6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0719.HK's P/E ratio is 13.31. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0719.HK's ROE of +0.06%. Regarding short-term risk, 0013.HK is more volatile compared to 0719.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 0719.HK's competition here
0013.HK vs 0570.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0570.HK has a market cap of 9.1B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0570.HK trades at HK$1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0570.HK's P/E ratio is -22.50. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0570.HK's ROE of -0.02%. Regarding short-term risk, 0013.HK is more volatile compared to 0570.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 0570.HK's competition here
0013.HK vs 2877.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2877.HK has a market cap of 7.5B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2877.HK trades at HK$9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2877.HK's P/E ratio is 6.86. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2877.HK's ROE of +0.12%. Regarding short-term risk, 0013.HK is less volatile compared to 2877.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2877.HK's competition here
0013.HK vs 2005.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2005.HK has a market cap of 7.3B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2005.HK trades at HK$2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2005.HK's P/E ratio is 15.50. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2005.HK's ROE of +0.06%. Regarding short-term risk, 0013.HK is less volatile compared to 2005.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2005.HK's competition here
0013.HK vs 2552.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2552.HK has a market cap of 3.7B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2552.HK trades at HK$3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2552.HK's P/E ratio is 2.93. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2552.HK's ROE of +1.07%. Regarding short-term risk, 0013.HK is less volatile compared to 2552.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2552.HK's competition here
0013.HK vs 2561.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2561.HK has a market cap of 2.9B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2561.HK trades at HK$26.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2561.HK's P/E ratio is -9.41. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2561.HK's ROE of -0.26%. Regarding short-term risk, 0013.HK is less volatile compared to 2561.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2561.HK's competition here
0013.HK vs 6896.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 6896.HK has a market cap of 2.7B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 6896.HK trades at HK$3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 6896.HK's P/E ratio is 8.76. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 6896.HK's ROE of +0.19%. Regarding short-term risk, 0013.HK is more volatile compared to 6896.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 6896.HK's competition here
0013.HK vs 2633.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2633.HK has a market cap of 2.4B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2633.HK trades at HK$1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2633.HK's P/E ratio is 8.00. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2633.HK's ROE of +0.13%. Regarding short-term risk, 0013.HK is less volatile compared to 2633.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 2633.HK's competition here
0013.HK vs 2161.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2161.HK has a market cap of 2.2B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2161.HK trades at HK$2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2161.HK's P/E ratio is 9.78. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2161.HK's ROE of +0.20%. Regarding short-term risk, 0013.HK is more volatile compared to 2161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 2161.HK's competition here
0013.HK vs 1061.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1061.HK has a market cap of 1.9B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1061.HK trades at HK$3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1061.HK's P/E ratio is 5.84. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1061.HK's ROE of +0.14%. Regarding short-term risk, 0013.HK is less volatile compared to 1061.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1061.HK's competition here
0013.HK vs 2348.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 2348.HK has a market cap of 1.7B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 2348.HK trades at HK$1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 2348.HK's P/E ratio is 8.54. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 2348.HK's ROE of +0.06%. Regarding short-term risk, 0013.HK is more volatile compared to 2348.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 2348.HK's competition here
0013.HK vs 3839.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 3839.HK has a market cap of 1.6B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 3839.HK trades at HK$6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 3839.HK's P/E ratio is 6.85. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 3839.HK's ROE of +0.12%. Regarding short-term risk, 0013.HK is more volatile compared to 3839.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 3839.HK's competition here
0013.HK vs 8049.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 8049.HK has a market cap of 1.4B. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 8049.HK trades at HK$2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 8049.HK's P/E ratio is 6.05. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 8049.HK's ROE of +0.14%. Regarding short-term risk, 0013.HK is less volatile compared to 8049.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 8049.HK's competition here
0013.HK vs 1349.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1349.HK has a market cap of 962.2M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1349.HK trades at HK$2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1349.HK's P/E ratio is -94.33. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1349.HK's ROE of -0.07%. Regarding short-term risk, 0013.HK is more volatile compared to 1349.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 1349.HK's competition here
0013.HK vs 1652.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1652.HK has a market cap of 901.9M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1652.HK trades at HK$1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1652.HK's P/E ratio is -61.00. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1652.HK's ROE of -0.03%. Regarding short-term risk, 0013.HK is less volatile compared to 1652.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1652.HK's competition here
0013.HK vs 0239.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0239.HK has a market cap of 760.4M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0239.HK trades at HK$2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0239.HK's P/E ratio is 10.61. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0239.HK's ROE of +0.13%. Regarding short-term risk, 0013.HK is more volatile compared to 0239.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 0239.HK's competition here
0013.HK vs 0503.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0503.HK has a market cap of 750.6M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0503.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0503.HK's P/E ratio is 13.77. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0503.HK's ROE of +0.07%. Regarding short-term risk, 0013.HK is less volatile compared to 0503.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0503.HK's competition here
0013.HK vs 3737.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 3737.HK has a market cap of 725.6M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 3737.HK trades at HK$0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 3737.HK's P/E ratio is 43.00. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 3737.HK's ROE of +0.02%. Regarding short-term risk, 0013.HK is less volatile compared to 3737.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 3737.HK's competition here
0013.HK vs 0950.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0950.HK has a market cap of 718.4M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0950.HK trades at HK$1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0950.HK's P/E ratio is 7.63. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0950.HK's ROE of +0.06%. Regarding short-term risk, 0013.HK is less volatile compared to 0950.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0950.HK's competition here
0013.HK vs 1011.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1011.HK has a market cap of 446.4M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1011.HK trades at HK$0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1011.HK's P/E ratio is -13.60. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1011.HK's ROE of +0.09%. Regarding short-term risk, 0013.HK is less volatile compared to 1011.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1011.HK's competition here
0013.HK vs 0897.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0897.HK has a market cap of 371.3M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0897.HK trades at HK$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0897.HK's P/E ratio is -33.00. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0897.HK's ROE of -0.01%. Regarding short-term risk, 0013.HK is less volatile compared to 0897.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0897.HK's competition here
0013.HK vs 8329.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 8329.HK has a market cap of 216.5M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 8329.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 8329.HK's P/E ratio is -4.30. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 8329.HK's ROE of -0.06%. Regarding short-term risk, 0013.HK is less volatile compared to 8329.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 8329.HK's competition here
0013.HK vs 0455.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0455.HK has a market cap of 208.6M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0455.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0455.HK's P/E ratio is -3.23. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0455.HK's ROE of -0.15%. Regarding short-term risk, 0013.HK is less volatile compared to 0455.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0455.HK's competition here
0013.HK vs 0858.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0858.HK has a market cap of 184.3M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0858.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0858.HK's P/E ratio is -0.51. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0858.HK's ROE of -0.30%. Regarding short-term risk, 0013.HK is less volatile compared to 0858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0858.HK's competition here
0013.HK vs 8622.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 8622.HK has a market cap of 170.1M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 8622.HK trades at HK$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 8622.HK's P/E ratio is -33.00. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 8622.HK's ROE of -0.12%. Regarding short-term risk, 0013.HK is more volatile compared to 8622.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0013.HK.Check 8622.HK's competition here
0013.HK vs 1498.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 1498.HK has a market cap of 125.6M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 1498.HK trades at HK$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 1498.HK's P/E ratio is -3.75. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 1498.HK's ROE of -0.30%. Regarding short-term risk, 0013.HK is less volatile compared to 1498.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 1498.HK's competition here
0013.HK vs 0911.HK Comparison April 2026
0013.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0013.HK stands at 21.3B. In comparison, 0911.HK has a market cap of 49.1M. Regarding current trading prices, 0013.HK is priced at HK$24.72, while 0911.HK trades at HK$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0013.HK currently has a P/E ratio of 5.96, whereas 0911.HK's P/E ratio is 0.08. In terms of profitability, 0013.HK's ROE is +0.41%, compared to 0911.HK's ROE of +0.01%. Regarding short-term risk, 0013.HK is less volatile compared to 0911.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0013.HK.Check 0911.HK's competition here